JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 447 articles

Articles by James Calloway

Northern Star Gains on Gold Rally Ahead of Half-Year Results
Earnings

Northern Star Gains on Gold Rally Ahead of Half-Year Results

Northern Star Resources shares climbed 3.6% as gold prices surpassed $5,000 per ounce. Investors await the company's FY26 half-year financial report, due before Thursday's market open.

GLD
CAR Group Soars on Strong Earnings, Dividend Boost and Confirmed Outlook
Earnings

CAR Group Soars on Strong Earnings, Dividend Boost and Confirmed Outlook

CAR Group shares surged over 10% after reporting a rise in first-half profit and increasing its interim dividend. The company reaffirmed its full-year revenue growth forecast.

CAR
Sigma Healthcare Shares Dip Ahead of Key Half-Year Results
Earnings

Sigma Healthcare Shares Dip Ahead of Key Half-Year Results

Sigma Healthcare shares declined nearly 1% in Monday trading as investors await the company's half-year financial report due February 26, focusing on margin performance and cost management.

XLV
Westpac Shares Climb to $40 Amid ASX Rally Ahead of Key Quarterly Report
Earnings

Westpac Shares Climb to $40 Amid ASX Rally Ahead of Key Quarterly Report

Westpac shares rose 1.47% to A$40.01 as the ASX 200 gained 1.85%. Investors await the bank's quarterly update on February 13, focusing on net interest margins and credit quality.

EWA
CSL Shares Edge Lower Ahead of Key Half-Year Results and Dividend Announcement
Earnings

CSL Shares Edge Lower Ahead of Key Half-Year Results and Dividend Announcement

CSL shares closed slightly lower as trading volume remained subdued, with investor focus shifting to the company's upcoming half-year financial results and interim dividend announcement scheduled for Wednesday.

CSL
Commonwealth Bank Shares Steady Ahead of Key Earnings and Dividend Announcement
Earnings

Commonwealth Bank Shares Steady Ahead of Key Earnings and Dividend Announcement

Commonwealth Bank of Australia shares held near A$160 as investors await the bank's half-year results and interim dividend decision due Wednesday.

CBAUF
ANZ Shares Gain Ahead of Key Quarterly Update and Mortgage Rate Hike
Earnings

ANZ Shares Gain Ahead of Key Quarterly Update and Mortgage Rate Hike

ANZ shares rose 1.7% to A$37.63 as investors await Thursday's first-quarter trading update. The bank will increase variable home loan rates by 0.25 percentage points from February 13.

ANZBY
Gilead Hits 52-Week Peak on FDA Label Expansion for Yescarta, Earnings in Focus
Regulation

Gilead Hits 52-Week Peak on FDA Label Expansion for Yescarta, Earnings in Focus

Gilead Sciences reached a 52-week high after the FDA approved a label update for its Yescarta therapy, expanding use to a rare brain lymphoma. The stock's rally comes ahead of the company's quarterly earnings report.

GILD
Disney Shares Face Regulatory Scrutiny as FCC Probes ABC Talk Show
Regulation

Disney Shares Face Regulatory Scrutiny as FCC Probes ABC Talk Show

Walt Disney Co's stock will be monitored Monday after U.S. regulators launched an investigation into ABC's 'The View' regarding election airtime rules. Shares closed Friday at $108.70, up 3.6%.

DIS
Novo Nordisk Rebounds as FDA Vows Crackdown on Wegovy Copycats
Regulation

Novo Nordisk Rebounds as FDA Vows Crackdown on Wegovy Copycats

Novo Nordisk B shares surged 5.29% after Hims & Hers halted its $49 compounded version of Wegovy, with the FDA pledging action against unauthorized copycats. The stock remains down roughly 20% over five sessions amid pricing uncertainty.

NVO LLY HIMS
Amgen Hits 52-Week Peak on Strong Earnings; Key Data, Dividend Date Ahead
Earnings

Amgen Hits 52-Week Peak on Strong Earnings; Key Data, Dividend Date Ahead

Amgen shares surged 4.5% to a 52-week high of $384.32, fueled by robust quarterly results and a dividend declaration. Investors now await delayed U.S. jobs and inflation figures.

AMGN CVS DOW SPY XLV
Inditex Initiates Share Repurchase Ahead of March Earnings
Earnings

Inditex Initiates Share Repurchase Ahead of March Earnings

Inditex shares edged higher Friday after announcing a €180 million buyback program for employee incentives, with full-year results due March 11.

BBVA